Skip to main content
. Author manuscript; available in PMC: 2018 Nov 9.
Published in final edited form as: J Clin Endocrinol Metab. 2015 Nov 20;101(1):131–142. doi: 10.1210/jc.2015-3019

Table 1. Body composition and metabolism during first year of Growth Hormone treatment.

Baseline 1-year P value
Anthropometry
      Height SDS -3.35 (0.74) -2.31 (0.69) <0.0001
      Weight SDS -3.10 (1.03) -2.12 (1.00) <0.0001
      BMI (kg/m2) 14.16 (1.49) 14.68 (1.62) <0.0001
      BMI SDS -1.34 (1.38) -0.96 (1.29) <0.0001
Body Composition (DXA)
      Total lean mass (kg) 11.5 (2.66) 15.6 (3.45) <0.0001
      Bone Mineral Content (g) 457 (166) 606 (188) <0.0001
      Total body fat mass (kg) 2.26 (1.06) 2.06 (1.12) 0.007
      Trunk fat mass (kg) 0.68 (0.37) 0.72 (0.41) 0.13
      Limbs fat mass (kg) 1.10 (0.68) 1.00 (0.67) 0.0002
      Total body fat (%) 15.8 (5.80) 11.2 (4.70) <0.0001
      total body fat % (z-score)* -0.26 (1.21) -1.23 (1.54) <0.0001
      Trunk fat (%) 10.6 (4.66) 8.63 (4.03) <0.0001
      Limb fat (%) 23.1 (9.70) 14.6 (7.70) <0.0001
      Trunk-limb fat ratio 0.61 (0.20) 0.84 (0.32) <0.0001
Biochemistry
      IGF- I (SDS) -1.09 (1.28) 2.88 (1.52) <0.0001
      Glucose (mmol/l) 4.32 (0.66) 4.70 (0.55) <0.0001
      Insulin (pmol/l) (log) 1.19 (0.28) 1.59 (0.22) <0.0001
      C-peptide (pmol/l) (log) 2.30 (0.24) 2.61 (0.17) <0.0001
      Insulin sensitivity (HOMA) (log) 2.38 (0.25) 2.06 (0.17) <0.0001
      Acute Insulin Response (log) 3.13 (0.24) 3.39 (0.26) <0.0001
      Disposition Index (log) 5.51 (0.24) 5.46 (0.23) 0.11
      Total Cholesterol (mmol/L) 3.94 (0.72) 3.88 (0.70) 0.38
      LDL Cholesterol (mmol/L) 2.23 (0.63) 2.15 (0.58) 0.11
      HDL Cholesterol (mmol/L) 1.47 (0.35) 1.42 (0.33) 0.070
      Triglycerides (mmol/L) 0.64 (0.33) 0.83 (0.40) 0.001

Data presented as means (SD)

*

Z-scores for percentage body fat calculated based on normative data (z-scorep)